Oppenheimer Issues Positive Forecast for Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price
Sensei Biotherapeutics (NASDAQ:SNSE – Free Report) had its target price boosted by Oppenheimer from $3.50 to $4.00 in a research report report published on Friday morning,Benzinga reports. The firm currently has an outperform rating on the stock. Separately, HC Wainwright reaffirmed a “buy” rating and set a $4.00 price target on shares of Sensei Biotherapeutics […]
